Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery
Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey
BeiGene, a global biotechnology company, announced today that the last piece of structural steel will […]
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Mediar Therapeutics, a biotechnology company advancing a portfolio of first-in-class therapies that halt and even […]
Teitur Trophics Raises €28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases
Teitur Trophics, a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative […]
Aldevron and Evanoa Sign Licensing Agreement
Evanoa Bioscience, a cell line developer for biologics manufacturing, together with Aldevron, a global leader […]
Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round led by Forbion and Jeito Capital
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that […]
Lipella Pharmaceuticals Announces Creation of Oral Health Scientific Advisory Board
Lipella Pharmaceuticals, a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has announced […]
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]
Investigational Therapy UGN-102 May Be Delivered at Home for the Treatment of Bladder Cancer
UroGen Pharma, a biotech company dedicated to developing and commercializing innovative treatment of urothelial and […]
Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine
Morphoceuticals, a biotechnology company, announced it closed an $8 million Seed-2 funding round led by […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more